Chronic Graft Rejection Completed Phase 4 Trials for Regadenoson (DB06213)

Also known as: Chronic graft rejection (finding)

IndicationStatusPhase
DBCOND0077076 (Chronic Graft Rejection)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02597543Stress Cardiac MRI for Evaluation of Nonspecific Allograft DysfunctionDiagnostic